课题基金 / 基金详情

Mechanisms of prostate cancer prevention by lycopene

Mechanisms of prostate cancer prevention by lycopene
番茄红素预防前列腺癌的机制
批准号:
6618508
负责人:
RICHARD B VAN BREEMEN
金额:
$33.53万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-06-17 至 2008-05-31

项目摘要

项目成果

RICHARD B VAN BREEMEN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 番茄红素是番茄的红色色素,是一种饮食中的类胡萝卜素和一种有效的抗氧化剂,前瞻性和回溯性流行病学研究表明,番茄红素与降低男性前列腺癌的发病率有关。我们对前列腺癌男性患者的初步临床研究表明,口服番茄红素可提高血清和前列腺番茄红素水平,降低血清前列腺特异性抗原(PSA)。我们使用人前列腺癌细胞进行的初步细胞培养研究表明,番茄红素选择性地被雄激素敏感的前列腺癌LNCaP细胞株吸收并抑制其增殖,但不能抑制雄激素不敏感的前列腺癌DU145和PC-3细胞的增殖。我们建议通过测量和比较雄激素敏感的细胞系LNCaP、PZ-HPV-7和BPH-1(分别代表人类前列腺癌、BPH和正常上皮细胞)和雄激素不敏感的前列腺癌DU145、PC-3、C4-2B和CWR22Rv1细胞对番茄红素的摄取率来扩展这些细胞培养研究。番茄红素的摄取率是否与这些细胞的增殖抑制成反比将被确定。为了阐明番茄红素作为抗增殖剂的作用机制,我们将测量番茄红素在亚细胞中的分布,然后使用ICAT定量蛋白质组学方法研究全球和亚细胞水平上蛋白质表达的变化。此外,将制备番茄红素亲和柱,并用于筛选番茄红素敏感细胞的番茄红素受体或结合蛋白,将使用基于质谱仪的蛋白质组学进行鉴定。番茄红素与雄激素受体的结合也将被研究。基于我们观察到的番茄红素降低前列腺癌男性患者PSA水平的观察,我们将研究番茄红素处理的前列腺癌细胞在培养过程中如何改变细胞内PSA的表达和分泌;此外,我们还将确定接受番茄红素补充剂的健康男性血清中总PSA和游离PSA是否发生变化。最后,我们将使用稳定同位素标记的番茄红素和高效液相-串联质谱仪来确定两种潜在的治疗剂量番茄红素的生物利用度和半衰期,分别为每天30毫克和每天60毫克。这些人体研究将为未来研究番茄红素化学预防前列腺癌的临床试验设计提供重要信息。
英文摘要
DESCRIPTION (provided by applicant): Lycopene, the red pigment of the tomato, is a dietary carotenoid and a potent antioxidant that has been associated by prospective and retrospective epidemiological studies with a decreased incidence of prostate cancer in men. Our preliminary clinical studies in men with prostate cancer indicate that oral administration of lycopene elevates serum and prostate lycopene levels and reduces serum prostate specific antigen (PSA). Our preliminary cell culture studies using human prostate cancer cells show that lycopene is absorbed selectively by and inhibits the proliferation of the androgen sensitive prostate cancer cell line LNCaP but not the androgen-insensitive prostate cancer cell lines DU145 and PC-3. We propose to expand upon these cell culture studies by measuring and comparing the rates of lycopene uptake by the androgen-sensitive cell lines LNCaP, PZ-HPV-7, and BPH-1 (which represent human prostate cancer, BPH, and normal epithelial cells, respectively), and the androgen-insensitive prostate cancer cell lines DU145, PC-3, C4-2B, and CWR22Rv1. Whether the rates of lycopene uptake are inversely proportional to inhibition of proliferation in these cells will be determined. In order to clarify the mechanism of action of lycopene as an antiproliferative agent, we will measure the sub-cellular distribution of lycopene and then investigate changes in protein expression both globally and on the sub-cellular level using the ICAT quantitative proteomics methodology. In addition, a lycopene affinity column will be prepared and used to screen lycopene sensitive cells for a lycopene receptor or binding protein which will be identified using mass spectrometry-based proteomics. Lycopene binding to the androgen receptor will also be investigated. Based on our observation that lycopene reduces PSA levels in men with prostate cancer, we will investigate how the intracellular expression and secretion of PSA is altered by prostate cells treated with lycopene in culture; in addition, we will determine whether total PSA and percent-free PSA are altered in the serum of healthy men receiving lycopene supplements. Finally, we will determine the bioavailability and half-life of two potentially therapeutic doses of lycopene, 30 mg per day and 60 mg per day, using stable isotope labeled lycopene and HPLC-tandem mass spectrometry. These human studies will provide vital information for the design of future clinical trials investigating the chemoprevention of prostate cancer by lycopene.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Training in Natural Product Complementary and Alternative Medicine
  • 批准号:
    8414581
  • 项目类别:
  • 资助金额:
    $22.93万
  • 财政年份:
    2013
  • 负责人:
    RICHARD B VAN BREEMEN
  • 依托单位:
Rapid Identification of Active Agents and Metabolomics of Botanical Supplements
  • 批准号:
    8703023
  • 项目类别:
  • 资助金额:
    $26.5万
  • 财政年份:
    2013
  • 负责人:
    RICHARD B VAN BREEMEN
  • 依托单位:
Botanical Dietary Supplements for Women's Health
  • 批准号:
    8607805
  • 项目类别:
  • 资助金额:
    $6.07万
  • 财政年份:
    2013
  • 负责人:
    RICHARD B VAN BREEMEN
  • 依托单位:
Rapid Identification of Active Agents and Metabolomics of Botanical Supplements
  • 批准号:
    9652301
  • 项目类别:
  • 资助金额:
    $9.08万
  • 财政年份:
    2013
  • 负责人:
    RICHARD B VAN BREEMEN
  • 依托单位:
海外基金